Physician profile
James Phillip Myatt
NPI 1871778001
$36,721.62
in general payments reported to CMS, 2019-2025
56 companies · $1,843 in 2025
The $1,843 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,769 · 2020: $3,802 · 2021: $4,223 · 2022: $6,466 · 2023: $7,975 · 2024: $8,645 · 2025: $1,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $6,234 · Debt Forgiveness: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,872.46 |
| Travel and Lodging | $6,233.61 |
| Debt Forgiveness | $1,356.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,197.11 | 2021-2025 | Hawkone, Abre, Corevalve Evolut R |
| Penumbra, INC. | $5,794.34 | 2019-2024 | Penumbra Coil 400, Indigo System, Benchmark |
| Abbott Laboratories | $5,142.63 | 2019-2025 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $3,214.88 | 2019-2020 | |
| Biotronik INC. | $2,607.67 | 2019-2025 | Amvia Edge, Edora 8 Dr-T, Recross |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,557.55 | 2019-2025 | Lifevest |
| Lantheus Medical Imaging, INC. | $1,356.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $1,086.09 | 2019-2025 | |
| Novo Nordisk INC | $639.25 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $597.77 | 2019-2023 | Xarelto |
| Pfizer INC. | $595.92 | 2019-2025 | |
| Abiomed | $563.52 | 2019-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $556.08 | 2019-2024 | Farxiga, Andexxa |
| Inari Medical, INC. | $505.80 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $496.08 | 2020-2025 | Repatha, Repatha |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $465.52 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $442.50 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $429.34 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $404.28 | 2021-2025 | Verquvo, Winrevair |
| Philips North America LLC | $345.64 | 2020-2025 | IV Other, (Az7) Lasers |
| Amarin Pharma, INC. | $298.12 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $221.90 | 2021-2022 | |
| Zoll Respicardia, INC. | $215.65 | 2023 | Remede System |
| Tactile Systems Technology INC | $186.38 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Angiodynamics, INC. | $151.53 | 2019-2025 | Auryon Laser System 100-120 Vac |
| Biosense Webster, INC. | $146.12 | 2025 | Carto 3 |
| Acist Medical Systems, INC. | $133.31 | 2019-2022 | |
| Vifor Pharma, INC. | $129.54 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $114.06 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $85.02 | 2022-2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $84.94 | 2022-2024 | Onpattro |
| Esperion Therapeutics, INC. | $82.40 | 2020-2022 | |
| Vital Connect, INC | $79.36 | 2023 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $77.58 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.72 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $67.03 | 2023 | Exparel, Iovera |
| Atricure, INC. | $55.68 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $46.25 | 2023-2024 | Uptravi, Opsumit |
| Avinger INC. | $45.16 | 2020 | |
| Stryker Corporation | $44.88 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $43.79 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $39.47 | 2024 | Arcalyst |
| Itamar Medical INC | $35.46 | 2022 | |
| Arbor Pharmaceuticals, INC. | $34.77 | 2019 | |
| Bard Peripheral Vascular, INC. | $28.57 | 2024 | Rotarexs 6 F X 135 Cm |
| Reflow Medical INC | $27.28 | 2025 | |
| Convatec INC. | $26.24 | 2023 | |
| Globus Medical, INC. | $25.73 | 2025 | Senza |
| Nevro Corp. | $21.17 | 2024 | Senza |
| Regeneron Healthcare Solutions, INC. | $21.03 | 2019 | |
| Corcept Therapeutics | $17.79 | 2023 | Korlym |
| Heartflow, INC. | $14.29 | 2024 | |
| Idorsia Pharmaceuticals US INC | $14.21 | 2023 | Quviviq |
| Cardiovascular Systems INC. | $13.38 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $13.24 | 2023 | Inpefa |
| Flowphysix INC | $11.60 | 2025 | Flowrunner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Myatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.